drugset

drugset / Trial / NCT00213070

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment

NCT00213070 ↗

Phase 3 Completed Sanwa Kagaku Kenkyusho Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus with treated insulin.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Miglitol	Small molecule	—	—

Indications